Found: 1
Select item for more details and to access through your institution.
Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials.
- Published in:
- British Journal of Dermatology, 2020, v. 183, n. 2, p. 242, doi. 10.1111/bjd.18898
- By:
- Publication type:
- Article